Champions Oncology, Inc.’s CSBR share price has dipped by 5.57%, which has investors questioning if this is right time to buy ...

Commissioners visit UD-based NIIMBL, where public-private partnerships promote innovation, workforce development ...

The news sent the stock of South San Francisco' Vaxart Inc. (Nasdaq: VXRT) nearly 17% higher Monday morning, or 6.7 cents, to ...

CM’s chief principal secretary and Kerala Infrastructure Investment Fund Board CEO, CMO member since 2021, more powerful than ...

Zymeworks' financial stability is evident with $76.3 million in revenue in 2024 and a cash runway extending through late 2027 ...

The global Live Cell Imaging Market, valued at US$2.88 billion in 2024, is forecasted to grow at a robust CAGR of 8.68%, reaching US$3.13 billion ...

Quantum Computing remains a speculative photonic bet, with upside on chip orders and downside on delivery risk. Check out why ...

German drug company Merck KGaA said Monday it has struck a deal to buy U.S. biotech firm SpringWorks Therapeutics for around ...

Animal-free egg protein intended to alleviate egg shortages will be coming from a biotech firm building its first plant in ...

Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 ...

Vietnam used to be known only as a great destination for casual travel and street food, but is now attracting the attention ...